S. Birndt

Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry

J. Panse, S. Ehl, Mathias W Pletz, 2020, Journal of Cancer Research and Clinical Oncology.

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.

K. Nichols, J. V. van Laar, R. Machowicz, 2019, Blood.

In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation

S. Scholl, D. Michel, T. Stamminger, 2019, Mediterranean journal of hematology and infectious diseases.

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation

M. Fellhauer, A. Hochhaus, I. Gehrke, 2020, Leukemia.

Contribution of Clonal Hematopoiesis to Adult-Onset Hemophagocytic Lymphohistiocytosis.

J. Aster, B. Ebert, A. Schram, 2020, Blood.

Identification of germline variants in adults with hemophagocytic lymphohistiocytosis.

J. Aster, B. Ebert, A. Schram, 2020, Blood advances.

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial

K. Döhner, K. Träger, D. Drömann, 2023, Leukemia.

Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis

U. Schnetzke, S. Birndt, A. Hochhaus, 2024, Leukemia.